Sawai Chief Wants Expert Panel to Discuss Delisting of Generics Deemed No Longer Necessary

Sawai Pharmaceutical President Kenzo Sawai Sawai Pharmaceutical President Kenzo Sawai on August 23 called on a soon-to-be-launched expert panel on drug distribution and pricing to discuss the possibility of allowing the delisting of listed medicines, particularly generics, when they are...read more